Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness

William R. Perlman, Maree J. Webster, Joel Kleinman, Cynthia Shannon Weickert

Research output: Contribution to journalArticle

Abstract

The amygdala is a limbic structure involved in the stress response and the regulation of emotional behaviors, both of which are disrupted in patients with neuropsychiatric illnesses. Because glucocorticoids are mediators of the stress response, we hypothesized that glucocorticoid receptor (GR) messenger ribonucleic acid (mRNA) levels might be altered in the amygdala. We also hypothesized that estrogen receptor α (ERα) mRNA expression might be altered in the amygdala, on the basis of observed gender differences in mental illness. Using quantitative film autoradiography after in situ hybridization with human GR and ERα probes, we measured mRNA levels on adjacent amygdala sections in four groups (n = 15 each of subjects with schizophrenia, major depressive disorder, and bipolar disorder, and unaffected control subjects) provided by the Stanley Consortium. We detected main effects of diagnosis and exposure to antidepressant medication on the levels of both mRNAs but no main effect of gender. Compared with control subjects, GR mRNA expression was reduced in the basolateral/lateral nuclei in schizophrenia and bipolar disorder. Estrogen receptor α mRNA levels were reduced in the basomedial nucleus in major depressive disorder and bipolar disorder. Our results support and extend previous findings describing a pattern of steroid hormone mRNA alterations that differs depending on which brain region is being examined in a given mental illness.

Original languageEnglish (US)
Pages (from-to)844-852
Number of pages9
JournalBiological Psychiatry
Volume56
Issue number11
DOIs
StatePublished - Dec 1 2004
Externally publishedYes

Fingerprint

Estrogen Receptor alpha
Amygdala
RNA
Glucocorticoid Receptors
Bipolar Disorder
Estrogen Receptors
Major Depressive Disorder
Schizophrenia
Autoradiography
Antidepressive Agents
Glucocorticoids
In Situ Hybridization
glucocorticoid receptor alpha
Steroids
Hormones
Messenger RNA
Brain

Keywords

  • Amygdala
  • antidepressants
  • bipolar disorder
  • depression
  • postmortem
  • schizophrenia

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. / Perlman, William R.; Webster, Maree J.; Kleinman, Joel; Weickert, Cynthia Shannon.

In: Biological Psychiatry, Vol. 56, No. 11, 01.12.2004, p. 844-852.

Research output: Contribution to journalArticle

@article{be9f32a3b095462daed8483366893e83,
title = "Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness",
abstract = "The amygdala is a limbic structure involved in the stress response and the regulation of emotional behaviors, both of which are disrupted in patients with neuropsychiatric illnesses. Because glucocorticoids are mediators of the stress response, we hypothesized that glucocorticoid receptor (GR) messenger ribonucleic acid (mRNA) levels might be altered in the amygdala. We also hypothesized that estrogen receptor α (ERα) mRNA expression might be altered in the amygdala, on the basis of observed gender differences in mental illness. Using quantitative film autoradiography after in situ hybridization with human GR and ERα probes, we measured mRNA levels on adjacent amygdala sections in four groups (n = 15 each of subjects with schizophrenia, major depressive disorder, and bipolar disorder, and unaffected control subjects) provided by the Stanley Consortium. We detected main effects of diagnosis and exposure to antidepressant medication on the levels of both mRNAs but no main effect of gender. Compared with control subjects, GR mRNA expression was reduced in the basolateral/lateral nuclei in schizophrenia and bipolar disorder. Estrogen receptor α mRNA levels were reduced in the basomedial nucleus in major depressive disorder and bipolar disorder. Our results support and extend previous findings describing a pattern of steroid hormone mRNA alterations that differs depending on which brain region is being examined in a given mental illness.",
keywords = "Amygdala, antidepressants, bipolar disorder, depression, postmortem, schizophrenia",
author = "Perlman, {William R.} and Webster, {Maree J.} and Joel Kleinman and Weickert, {Cynthia Shannon}",
year = "2004",
month = "12",
day = "1",
doi = "10.1016/j.biopsych.2004.09.006",
language = "English (US)",
volume = "56",
pages = "844--852",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "11",

}

TY - JOUR

T1 - Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness

AU - Perlman, William R.

AU - Webster, Maree J.

AU - Kleinman, Joel

AU - Weickert, Cynthia Shannon

PY - 2004/12/1

Y1 - 2004/12/1

N2 - The amygdala is a limbic structure involved in the stress response and the regulation of emotional behaviors, both of which are disrupted in patients with neuropsychiatric illnesses. Because glucocorticoids are mediators of the stress response, we hypothesized that glucocorticoid receptor (GR) messenger ribonucleic acid (mRNA) levels might be altered in the amygdala. We also hypothesized that estrogen receptor α (ERα) mRNA expression might be altered in the amygdala, on the basis of observed gender differences in mental illness. Using quantitative film autoradiography after in situ hybridization with human GR and ERα probes, we measured mRNA levels on adjacent amygdala sections in four groups (n = 15 each of subjects with schizophrenia, major depressive disorder, and bipolar disorder, and unaffected control subjects) provided by the Stanley Consortium. We detected main effects of diagnosis and exposure to antidepressant medication on the levels of both mRNAs but no main effect of gender. Compared with control subjects, GR mRNA expression was reduced in the basolateral/lateral nuclei in schizophrenia and bipolar disorder. Estrogen receptor α mRNA levels were reduced in the basomedial nucleus in major depressive disorder and bipolar disorder. Our results support and extend previous findings describing a pattern of steroid hormone mRNA alterations that differs depending on which brain region is being examined in a given mental illness.

AB - The amygdala is a limbic structure involved in the stress response and the regulation of emotional behaviors, both of which are disrupted in patients with neuropsychiatric illnesses. Because glucocorticoids are mediators of the stress response, we hypothesized that glucocorticoid receptor (GR) messenger ribonucleic acid (mRNA) levels might be altered in the amygdala. We also hypothesized that estrogen receptor α (ERα) mRNA expression might be altered in the amygdala, on the basis of observed gender differences in mental illness. Using quantitative film autoradiography after in situ hybridization with human GR and ERα probes, we measured mRNA levels on adjacent amygdala sections in four groups (n = 15 each of subjects with schizophrenia, major depressive disorder, and bipolar disorder, and unaffected control subjects) provided by the Stanley Consortium. We detected main effects of diagnosis and exposure to antidepressant medication on the levels of both mRNAs but no main effect of gender. Compared with control subjects, GR mRNA expression was reduced in the basolateral/lateral nuclei in schizophrenia and bipolar disorder. Estrogen receptor α mRNA levels were reduced in the basomedial nucleus in major depressive disorder and bipolar disorder. Our results support and extend previous findings describing a pattern of steroid hormone mRNA alterations that differs depending on which brain region is being examined in a given mental illness.

KW - Amygdala

KW - antidepressants

KW - bipolar disorder

KW - depression

KW - postmortem

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=9644302538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644302538&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2004.09.006

DO - 10.1016/j.biopsych.2004.09.006

M3 - Article

C2 - 15576061

AN - SCOPUS:9644302538

VL - 56

SP - 844

EP - 852

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 11

ER -